Q3FY17 Result: Dishman Pharmaceuticals & Chemicals Ltd
Bhagyashree Vivarekar / 13 Feb 2017
The company reported PAT of Rs 51 crore, which represents a sequential QoQ decline of 6.59 per cent and a YoY increase of 12.58 per cent.
Dishman Pharmaceuticals & Chemicals Ltd. reported its consolidated results for the quarter ended December 31, 2016 today.
The company reported sales of Rs 362 crore for Q3FY17, which represents a 17.07 per cent sequential decline and 7.68 per cent YoY decline.
Its operating profit (EBIT) for the quarter came in at Rs 66.4 crore with EBIT margin of 18.34 per cent.
The company reported PAT of Rs 51 crore, which represents a sequential QoQ decline of 6.59 per cent and a YoY increase of 12.58 per cent.
Dishman Pharmaceuticals & Chemicals Ltd is an outsourcing partner for pharmaceutical companies, offering a portfolio of products and development, scale-up and manufacturing services. The company operates in two segments, namely, contract research and contract manufacturing (CRAMS), and others (bulk drugs, intermediates, quats, speciality chemicals and traded goods.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.